PALO ALTO, Calif.----May 30, 2006--Connetics Corporation , a specialty pharmaceutical company that develops and commercializes dermatology products, today announced that the Company received notices from persons claiming to hold more than 25% of the aggregate outstanding principal amount of each of its 2.00% and 2.25% Convertible Senior Notes.


Click Here to read the entire article...